Brief: Alkermes Commences Arbitration Related To License Agreements With Janssen Pharmaceutica

Alkermes

19/04/2022 12:37

April 19 (Reuters) - Alkermes Plc  ALKS.O :
    * ALKERMES COMMENCES ARBITRATION RELATED TO LICENSE
AGREEMENTS
WITH JANSSEN PHARMACEUTICA
    * ALKERMES PLC - COMMENCED BINDING ARBITRATION PROCEEDINGS
IN
RESPECT OF TWO LICENSE AGREEMENTS WITH JANSSEN PHARMACEUTICA
N.V.
    * ALKERMES - UNDER AGREEMENTS, JANSSEN RECEIVED ACCESS,
RIGHTS TO
CO'S SMALL PARTICLE PHARMACEUTICAL COMPOUND TECHNOLOGY,
NANOCRYSTAL TECHNOLOGY
    * ALKERMES PLC - JANSSEN PARTIALLY TERMINATED AGREEMENTS IN
UNITED
STATES EFFECTIVE AS OF FEBRUARY 2022
    * ALKERMES PLC - COMPANY HAS ENGAGED WITH JANSSEN IN AN
EFFORT TO
COME TO A MUTUALLY AGREEABLE SETTLEMENT
    * ALKERMES PLC - NO RESOLUTION HAS BEEN ACHIEVED
    * ALKERMES PLC - ALKERMES REMAINS OPEN TO A MUTUALLY
AGREEABLE
RESOLUTION

Source text for Eikon:  ID:nPn7hsthKa 
Further company coverage:  ALKS.O